195 related articles for article (PubMed ID: 16020114)
41. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
42. Management of the febrile neutropenic patient.
Picazo JJ;
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492
[TBL] [Abstract][Full Text] [Related]
43. [Chemotherapy-induced febrile neutropenia: about 200 episodes. Clinical, microbiological and therapeutic characteristics].
Gharbi O; Ben Hadj Hassen S; Kaabia N; Limam S; Hadj Amor M; Ben Fatma L; Landolsi A; Hochlef M; Letaief A; Boukadida J; Ben Ahmed S
Pathol Biol (Paris); 2008 May; 56(3):154-7. PubMed ID: 18178025
[TBL] [Abstract][Full Text] [Related]
44. Management of fever in neutropenic patients with different risks of complications.
Klastersky J
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
[TBL] [Abstract][Full Text] [Related]
45. Mucocutaneous findings in febrile neutropenic children with acute leukemias.
Wananukul S; Nuchprayoon I; Siripanich H
J Med Assoc Thai; 2005 Jun; 88(6):817-23. PubMed ID: 16083222
[TBL] [Abstract][Full Text] [Related]
46. Bacterial infections in low-risk, febrile neutropenic patients.
Kamana M; Escalante C; Mullen CA; Frisbee-Hume S; Rolston KV
Cancer; 2005 Jul; 104(2):422-6. PubMed ID: 15937905
[TBL] [Abstract][Full Text] [Related]
47. Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.
Brunet AS; Ploton C; Galambrun C; Pondarré C; Pages MP; Bleyzac N; Freydière AM; Barbé G; Bertrand Y
Pediatr Blood Cancer; 2006 Nov; 47(6):765-72. PubMed ID: 16333838
[TBL] [Abstract][Full Text] [Related]
48. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
49. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia.
Hodgson-Viden H; Grundy PE; Robinson JL
BMC Pediatr; 2005 May; 5(1):10. PubMed ID: 15904510
[TBL] [Abstract][Full Text] [Related]
50. Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia.
Tamura K; Imajo K; Akiyama N; Suzuki K; Urabe A; Ohyashiki K; Tanimoto M; Masaoka T;
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S15-24. PubMed ID: 15250016
[TBL] [Abstract][Full Text] [Related]
51. Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome.
Stabell N; Nordal E; Stensvold E; Gammelsrud KW; Lund B; Taxt A; Buhring F; Greve-Isdahl M; Fornebo HP; Simonsen GS; Klingenberg C
Scand J Infect Dis; 2008; 40(4):301-7. PubMed ID: 17918015
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic implication of BAL in patients with neutropenia.
Kuehnhardt D; Hannemann M; Schmidt B; Heider U; Possinger K; Eucker J
Ann Hematol; 2009 Dec; 88(12):1249-56. PubMed ID: 19415277
[TBL] [Abstract][Full Text] [Related]
53. Febrile neutropenia in haematological malignancies.
Sharma A; Lokeshwar N
J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
[TBL] [Abstract][Full Text] [Related]
54. [Microbiological isolates in patients with febrile neutropenia and hematological neoplasias].
Figuera Esparza M; Carballo M; Silva M; Figueredo A; Avilán J
Rev Esp Quimioter; 2006 Sep; 19(3):247-51. PubMed ID: 17099792
[TBL] [Abstract][Full Text] [Related]
55. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
[TBL] [Abstract][Full Text] [Related]
56. Meropenem use and colonization by antibiotic-resistant Gram-negative bacilli in a pediatric intensive care unit.
Toltzis P; Dul M; O'Riordan MA; Melnick D; Lo M; Blumer J
Pediatr Crit Care Med; 2009 Jan; 10(1):49-54. PubMed ID: 19057450
[TBL] [Abstract][Full Text] [Related]
57. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
Przepiorka D; Buadi FK; McClune B
Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
[TBL] [Abstract][Full Text] [Related]
58. [Infectious complications in pediatric cancer patients].
Lehrnbecher T; Laws HJ
Klin Padiatr; 2005 Nov; 217 Suppl 1():S3-8. PubMed ID: 16288349
[TBL] [Abstract][Full Text] [Related]
59. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
[TBL] [Abstract][Full Text] [Related]
60. Clinical implications of icaA and icaD genes in coagulase negative staphylococci and Staphylococcus aureus bacteremia in febrile neutropenic pediatric cancer patients.
El-Mahallawy HA; Loutfy SA; El-Wakil M; El-Al AK; Morcos H
Pediatr Blood Cancer; 2009 Jul; 52(7):824-8. PubMed ID: 19214976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
